Corteva Completes Spin-Off of Seed Business Vylor; Stock Falls 84%

What happened

Corteva, Inc. (ticker CTVA) completed the spin-off of its seed and genetics business into a new independent company called Vylor on Oct. 1, 2026, according to PR Newswire releases from the company. Corteva said it has begun operating as a focused crop-protection business.

The remaining CTVA shares closed at $12.57 that day, down 83.81% from the previous close of $77.65, according to the price data. Volume was 87,997,473 shares, about 19.6 times the average volume of 4,497,627 — a signal that the day's trading was dominated by the restructuring rather than ordinary buying and selling.

Yahoo Finance reported the shares crashed 83% after the spin-off. Barron's reported an 81% drop in pre-market trading. Benzinga reported an 82% drop and said the move reflects the corporate restructuring rather than a fundamental collapse.

Corteva also announced that Vylor's Form 10 registration statement had become effective, confirming the separation, per PR Newswire. Seeking Alpha reported court clearance of the Vylor separation.

Why the price fell so far

When a company spins off a business, it hands part of itself to shareholders as shares of a new, separately traded company. The parent company is then worth less because it no longer owns the spun-off business.

Corteva's seed and genetics business was the larger piece of the company by revenue. Its most recent annual revenue was $17.4 billion for the period ending Dec. 31, 2025. After the spin-off, the remaining Corteva is a crop-protection company — the part that makes and sells products like herbicides, insecticides and fungicides rather than seeds and genetic traits.

That is why the quoted CTVA price fell by more than 80% in a single session. The drop mostly reflects the removal of the seed business from Corteva's ownership, not a judgment by the market that the crop-protection business is worth 84% less than the old combined company. Investors who held CTVA before the spin-off should also have received shares of Vylor, which would carry the value of the seed and genetics business.

What this means

A spin-off is a way for a company to split itself into two separately traded public companies. The parent transfers a business unit to a new entity and distributes that entity's shares to existing shareholders, usually pro rata — meaning if you owned a slice of Corteva, you received a proportionate slice of Vylor.

A Form 10 registration statement is the document a company files with the SEC to register a new class of securities under the Securities Exchange Act of 1934. For a spin-off, the new company files a Form 10 describing its business, financials and management before its shares can be listed and traded. Corteva's announcement that Vylor's Form 10 had become effective meant the separation could go forward.

The key mechanical point for readers: the big percentage drop in CTVA on the spin-off date is not the same as a big percentage loss for a shareholder who held through the transaction. The shareholder's total holdings — CTVA plus the new Vylor shares — should reflect both companies. Quote services often show only the CTVA leg, which is what makes the headline number look catastrophic.

Corteva described the remaining company as an "innovation-led global crop protection leader" in its PR Newswire release. Vylor is the seed and genetics business; Corteva is now the crop-protection business. Both are separate public companies going forward.

What the sources do not establish

None of the verified sources reviewed for this article explain why Corteva chose to separate the two businesses or describe the strategic rationale in detail.

Two other explanations circulated online. One article on stockstotrade.com attributed a CTVA drop to a $455 million PFAS settlement; an AlphaStreet article said sector-wide selling in agriculture stocks amplified the move. Neither claim was confirmed by the company filings or the major outlets cited above, and this article does not treat them as established.

Corteva's revenue figure cited here ($17.4 billion, period ending Dec. 31, 2025) is the most recent annual figure provided and predates the spin-off, so it reflects the combined company, not the remaining crop-protection business on its own.